The activity of the chaperonin CCT/TRiC is impaired in devastating neuropathies and in Alzheimer's disease and has been proposed to regulate the aggregation of proteins like mutant huntingtin. Here, MARVELD2 is linked to early-onset autosomal dominant Alzheimer disease.